AU2001219299A1 - Drug target isogenes: polymorphisms in the interleukin 3 (colony-stimulating factor, multiple) gene - Google Patents

Drug target isogenes: polymorphisms in the interleukin 3 (colony-stimulating factor, multiple) gene

Info

Publication number
AU2001219299A1
AU2001219299A1 AU2001219299A AU1929901A AU2001219299A1 AU 2001219299 A1 AU2001219299 A1 AU 2001219299A1 AU 2001219299 A AU2001219299 A AU 2001219299A AU 1929901 A AU1929901 A AU 1929901A AU 2001219299 A1 AU2001219299 A1 AU 2001219299A1
Authority
AU
Australia
Prior art keywords
polymorphisms
interleukin
colony
gene
stimulating factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001219299A
Other languages
English (en)
Inventor
Anne Chew
R. Rex Denton
Krishnan Nandabalan
J. Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU2001219299A1 publication Critical patent/AU2001219299A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001219299A 2000-11-28 2000-11-28 Drug target isogenes: polymorphisms in the interleukin 3 (colony-stimulating factor, multiple) gene Abandoned AU2001219299A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/032381 WO2002044410A1 (fr) 2000-11-28 2000-11-28 Isogenes de ciblage de medicament: polymorphismes dans le gene de l'interleukine 3 (multiple, facteur de croissance hematopoietique)

Publications (1)

Publication Number Publication Date
AU2001219299A1 true AU2001219299A1 (en) 2002-06-11

Family

ID=21742030

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001219299A Abandoned AU2001219299A1 (en) 2000-11-28 2000-11-28 Drug target isogenes: polymorphisms in the interleukin 3 (colony-stimulating factor, multiple) gene

Country Status (2)

Country Link
AU (1) AU2001219299A1 (fr)
WO (1) WO2002044410A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
CA2306446A1 (fr) * 1998-09-25 2000-04-06 Massachusetts Institute Of Technology Procedes et produits associes a la determination d'un genotype et a l'analyse de l'adn

Also Published As

Publication number Publication date
WO2002044410A1 (fr) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2002345250A1 (en) Plant disease resistance genes
AU2001273063A1 (en) Stabilized interleukin 2
AU2001272482A1 (en) Osteolevin gene polymorphisms
AUPR311601A0 (en) Matrix gene expression in chondrogenesis
AU2000263446A1 (en) Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene
AU2002345437A1 (en) Nucleotide sequences involved in plant disease resistance
AU2001219299A1 (en) Drug target isogenes: polymorphisms in the interleukin 3 (colony-stimulating factor, multiple) gene
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU2002367465A1 (en) Multiple controls for molecular genetic analyses
AU2001229768A1 (en) Amplified genes at 17q23
AU2002337671A1 (en) Polymorphisms associated with multiple sclerosis
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
AU2001284288A1 (en) Plant resistance gene
AU5429999A (en) Plant resistance gene
AU2001274256A1 (en) Plant resistance gene
AU2000277254A1 (en) Drug target isogenes: polymorphisms in the interleukin-4 gene
AU7788000A (en) Multiple-level furnace
AU2001239750A1 (en) Haplotypes of the interleukin 15 gene
AU6871900A (en) Tsg-like gene
AU7706000A (en) Drug target isogenes: polymorphisms in the interleukin-1 beta gene
AU4808200A (en) Dna balls
AU2001229100A1 (en) Drug target isogenes: polymorphisms in the neuropeptide y gene
AU6755300A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU2000278606A1 (en) Drug target isogenes: polymorphisms in the death-associated protein 6 gene
AU1538201A (en) Resistance gene